Skip to main content
Kathryn R. Byrne
( out of 60 reviews )

Kathryn R. Byrne, MD

Languages spoken: English

Clinical Locations

Primary Location

Gastroenterology /GI Clinic UUH

Gastroenterology, Area E
50 N Medical Dr
Salt Lake City , UT 84132

Huntsman Cancer Institute - Cancer Hospital North

1K, Endoscopy
1950 Circle of Hope
Salt Lake City , UT 84112

Redwood Health Center

General Endoscopy
1525 West 2100 South
Salt Lake City , UT 84119

University of Utah Hospital

Gastroenterology Endoscopy Center
50 N Medical Dr
Salt Lake City , UT 84132

Kathryn R. Byrne, M.D., is an Associate Clinical Professor at the University of Utah Hospital, Redwood Endoscopy Center, and the Veterans Medical Center. As a Gastroenterologist, her clinical and research interests include diagnostic EUS, complex polypectomy, medical education and endoscopic therapy for Barrett's esophagus and early stage esophageal cancer.


Dr. Byrne received her Medical Degree from the University of Texas Medical School at Houston. She received training in Internal Medicine and Gastroenterology from the University of Utah. She completed an advanced endoscopy fellowship at the Medical College of Wisconsin. She is currently a member of the American Medical Association, the American Gastroenterological Association, the American College of Gastroenterology, and the American Society for Gastrointestinal Endoscopy.

Board Certification

American Board of Internal Medicine
American Board of Internal Medicine (Sub: Gastroenterology)

Patient Rating

Patients consistently describe Dr. Byrne as knowledgeable, competent, and trustworthy, noting that she explains conditions and treatments clearly and makes them feel safe. Reviewers highlight her attentive, empathetic communication—she listens, makes time for questions, and coordinates with other team members during visits. Many comments also praise the supportive, professional care team and the convenience of virtual visits, contributing to a calm and reassuring experience.

Generated via Patient Reviews

4.8 /5
( out of 60 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.


Dec 11, 2025
UNIVERSITY HOSPITAL

I feel very safe under her care and procedures.

Jun 04, 2025
UNIVERSITY HOSPITAL

Sweet understanding and knowledgeable thank you Dr. Byrne

Mar 20, 2025
UNIVERSITY HOSPITAL

Dr. Byrne has been amazing to work with. She's obviously very credible and busy. But she's never made me feel as she's too busy when meeting. She and her team have done everything in their power to help me. It means more than they know.


Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

Board Certification and Academic Information

Academic Departments Internal Medicine -Professor (Clinical)
Academic Divisions Gastroenterology
Board Certification
American Board of Internal Medicine
American Board of Internal Medicine (Sub: Gastroenterology)

Education history

Fellowship Therapeutic Endoscopy - Medical College of Wisconsin/Milwaukee VAMC Advanced Fellow
Fellowship University of Utah, School of Medicine, Department of Internal Medicine (Gastroenterology) Fellow
Residency Internal Medicine - University of Utah, School of Medicine, Department of Internal Medicine Resident
Professional Medical Medicine - University of Texas Medical School at Houston M.D.
Undergraduate Biochemistry - Texas A&M University B.S.

Selected Publications

Journal Article

  1. Toy G, Cardell E, Fang JC, Latham J, Mudrow N, Byrne K, Ramai D (2025). Positive provocative testing and symptom evaluation for detecting upper extremity repetitive use injuries among endoscopists. Endosc Int Open, 13, a26061076.
  2. Dong ZM, Fang J, Byrne KR, Bronner MP, Hale GL (2021). Histologic mimics and diagnostic pitfalls of gastrointestinal endoscopic lifting media, ORISE™ gel and Eleview®. Hum Pathol, 119, 28-40.
  3. Aihara H, Dacha S, Anand GS, Byrne KR, Chahal P, James T, Kowalski TE, Repaka A, Saadi M, Sheth SG, Taylor JR, Williams RL, Wagh MS (2021). Core curriculum for endoscopic submucosal dissection (ESD). Gastrointest Endosc, 93(6), 1215-1221.
  4. Qayed E, Sheth SG, Aihara H, Anand GS, Byrne KR, Chahal P, Dacha S, James T, Kowalski TE, Repaka A, Saadi M, Taylor JR, Williams RL, Wagh MS, ASGE Training Committee Chair (2021). Advanced endoscopy fellowship training in the United States: recent trends in American Society for Gastrointestinal Endoscopy advanced endoscopy fellowship match, trainee experience, and postfellowship employment. Gastrointest Endosc, 93(6), 1207-1214.e2.
  5. Dacha S, Aihara H, Anand GS, Byrne KR, Chahal P, James T, Kowalski TE, Qayed E, Repaka A, Saadi M, Sheth SG, Taylor JR, Walsh CM, Williams RL, Wagh MS (2021). Core curriculum for peroral endoscopic myotomy (POEM). Gastrointest Endosc, 93(3), 539-543.
  6. Sample DC, Samadder NJ, Pappas LM, Boucher KM, Samowitz WS, Berry T, Westover M, Nathan D, Kanth P, Byrne KR, Burt RW, Neklason DW (2018). Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients. BMC Gastroenterol, 18(1), 115.
  7. Samadder NJ, Kuwada SK, Boucher KM, Byrne K, Kanth P, Samowitz W, Jones D, Tavtigian SV, Westover M, Berry T, Jasperson K, Pappas L, Smith L, Sample D, Burt RW, Neklason DW (2018). Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol, 4(5), 671-677.
  8. Delker DA, Wood AC, Snow AK, Samadder NJ, Samowitz WS, Affolter KE, Boucher KM, Pappas LM, Stijleman IJ, Kanth P, Byrne KR, Burt RW, Bernard PS, Neklason DW (2018). Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia. Cancer Prev Res (Phila), 11(1), 4-15.
  9. Samadder NJ, Smith KR, Wong J, Hanson H, Boucher K, Burt RW, Charlton M, Byrne KR, Gallegos-Orozco JF, Koptiuch C, Curtin K (2016). Familial Risk of Biliary Tract Cancers: A Population-Based Study in Utah. Dig Dis Sci, 61(12), 3627-3632.
  10. Samadder NJ, Neklason DW, Boucher KM, Byrne KR, Kanth P, Samowitz W, Jones D, Tavtigian SV, Done MW, Berry T, Jasperson K, Pappas L, Smith L, Sample D, Davis R, Topham MK, Lynch P, Strait E, McKinnon W, Burt RW, Kuwada SK (2016). Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial. JAMA, 315(12), 1266-75.
  11. Peterson KA, Byrne KR, Vinson LA, Ying J, Boynton KK, Fang JC, Gleich GJ, Adler DG, Clayton F (2013). Elemental diet induces histologic response in adult eosinophilic esophagitis. Am J Gastroenterol, 108(5), 759-66.
  12. Byrne KR, Adler DG (2011). Marathon pancreatitis. J Clin Gastroenterol, 45(2), 178-9.
  13. Byrne KR, Panagiotakis PH, Hilden K, Thomas KL, Peterson KA, Fang JC (2007). Retrospective analysis of esophageal food impaction: differences in etiology by age and gender. Dig Dis Sci, 52(3), 717-21.